1. Volume 18, Issue 1, Pages 61-68 (February 2011)
Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case–control diffusion imaging study 
R. Zivadinov, Sara Hussein, Milena Stosic, Jacqueline Durfee, Jennifer L. Cox, Diane L. Cookfair, Komal Hashmi, Nadir Abdelrahman, Neeta Garg, Michael G. Dwyer, B. Weinstock-Guttman 
Pathophysiology 
Volume 18, Issue 1, Pages (February 2011)
DOI: /j.pathophys
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1
Percent within-subject change from baseline in diffusion-weighted imaging (DWI) measures after 12 and 24 months of glatiramer acetate therapy in MS patients and healthy controls. MPD: mean parenchymal diffusivity; RRMS: relapsing–remitting multiple sclerosis; HC: healthy controls.
Pathophysiology  , 61-68DOI: ( /j.pathophys )
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions